
|Videos|July 14, 2015
Q&A With Guido Stirnimann, MD, From University of Bern: Further Cirrhosis Education Beneficial for Advancements in Treatment
Author(s)Amy Jacob
Cirrhosis is a serious problem for patients with the condition and while treatment has made great strides in recent years there is still more that can be learned to help more patients with more effective treatments.
Advertisement
Cirrhosis is a serious problem for patients with the condition and while treatment has made great strides in recent years there is still more that can be learned to help more patients with more effective treatments.
Guido Stirnimann, MD, University of Bern, spoke about the brevity of the poor prognosis advanced cirrhosis patients face during the European Association for the Study of the Liver's 50th Annual International Liver Congress in Vienna.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
3
High-Dose Semaglutide Preserves Kidney Function, Reduces Inflammation in Obesity Without Diabetes
4
Semaglutide 7.2 mg Shows Greater BMI, Cardiometabolic Gains in T2D
5


























































